home / stock / syn / syn news

SYN News and Press, Synthetic Biologics Inc. From 02/20/20

Stock Information
Company Name: Synthetic Biologics Inc.
Stock Symbol: SYN
Market: NYSE
Website: syntheticbiologics.com
Menu
SYN SYN Quote SYN Short SYN News SYN Articles SYN Message Board
Get SYN Alerts

News, Short Squeeze, Breakout and More Instantly...
SYN - Synthetic Biologics Reports 2019 Year End Operational Highlights and Financial Results

ROCKVILLE, Md. , Feb. 20, 2020 /PRNewswire/ -- Synthetic Biologics, Inc.  (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, ...
SYN - Synthetic Biologics to Report 2019 Year End Operational Highlights and Financial Results on February 20, 2020

ROCKVILLE, Md . , Feb. 13, 2020 /PRNewswire/ --  Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, intends ...

SYN - Synthetic Biologics Announces Acceptance of Compliance Plan by NYSE American

ROCKVILLE, Md. , Feb. 7, 2020 /PRNewswire/ --   Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, announced...

SYN - Synthetic Biologics to Present at the 2020 BIO CEO & Investor Conference

ROCKVILLE, Md. , Feb. 4, 2020 /PRNewswire/ --  Synthetic Biologics , Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, announce...
SYN - Top 5 Reasons To Own Ally Financial

(The McLaren 650S Spider - Image Source ) This beautiful image from Ally Financial ( ALLY ) web site initially referred to Ally and McLaren announcing their financing relationship, but perhaps it can also symbolize exciting opportunities with ALLY stock. Introduction A month ago...

SYN - Synovus slips 1.5% as Q4 EPS disappoints

Synovus Financial (NYSEMKT: SYN ) falls 1.5%  in premarket trading after Q4 adjusted EPS of 94 cents trails the consensus estimate of 97 cents. More news on: Synthetic Biologics, Inc., Financial stocks news, Earnings news and commentary, , Stocks on the move, , Read more ...

SYN - Synthetic Bio up 9% on advancement of co-lead candidate

Thinly traded nano cap Synthetic Biologics ( SYN +8.7% ) is up a 17x surge in volume in reaction to its update on co-lead candidate SYN-004 (ribaxamase). More news on: Synthetic Biologics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

SYN - Synthetic Biologics Receives FDA Guidance at Type C Meeting for SYN-004 (ribaxamase) Phase 1b/2a Clinical Trial in Allogeneic HCT Recipients

ROCKVILLE, Md. , Jan. 7, 2020 /PRNewswire/ --  Synthetic Biologics, Inc.  (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, today ...

SYN - Synthetic Biologics Reports on NYSE American Noncompliance Notice and Compliance Plan

ROCKVILLE, Md. , Nov. 27, 2019 /PRNewswire/ --  Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, today anno...

SYN - Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q3 2019 Results - Earnings Call Transcript

Synthetic Biologics, Inc. (SYN) Q3 2019 Earnings Conference Call November 04, 2019, 16:30 PM ET Company Participants Vincent Perrone - Director, Corporate Communications Steven Shallcross - CEO and CFO Michael Kaleko - SVP of Research and Development Vince Wacher - Head of Prod...
Previous 10 Next 10